Nouvelle déclaration d'incident
No de la demande: 2012-2219
Numéro de référence du titulaire d'homologation: PROSAR Case : 1-30141312
Nom du titulaire (nom légal complet, aucune abbréviation): Syngenta Canada Inc.
Adresse: 140 Research Lane, Research Park
Ville: Guelph
État: Ontario
Pays: Canada
Code postal /Zip: N1G4Z3
Incident chez l'humain
Pays: UNITED STATES
État: MISSISSIPPI
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 100-1091
Nom du produit: Reward Landscape And Aquatic Herbicide
Liquide
Non
Non
Personne affectée
Sexe: Homme
Âge: >19 <=64 yrs / >19 <=64 ans
Système
Unknown / Inconnu
Oui
Oui
4
Day(s) / Jour(s)
Professionnel
Empoisonnement par ingestion d'un produit
Inconnu
Orale
Unknown / Inconnu
<=30 min / <=30 min
1-30141312- the reporter called to indicate exposure to an herbicide containing the active ingredient Diquat. The reporter indicated just preceding his call he had placed the concentrated product in a beverage bottle for transport to the field for use. He had inadvertently taken a drink from that beverage bottle. He estimated consumption of one fluid ounce. The caller was advised of appropriate first aid on the scene and directed to seek immediate medical attention, emergency medical transport if necessary. The reporter spontaneously called back thirty minutes later. He reported he spontaneously vomited and felt much better. He asked if he still needed to see the doctor. The caller was once again directed to seek immediate medical attention, emergency medical transport if necessary. Within twenty minutes an emergency room physician attending the patient called. He described a hemodynamically stable patient with oral irritation. His plan was supportive care (intravenous fluids, Zofran, and a chemistry profile). The physician was advised of standards of care following the described exposure. He revised his plan to include chest radiograph, liver profile, and EKG. He reported he would also consider keeping the patient in the hospital for observation. Product literature was supplied to the physician via FAX. On follow up one day later the registrant was unable to contact a health care provider involved in the patients care. The patient was admitted to the hospital but was in the midst of transfer between departments. On follow up one additional day later the registrant was able to contact the nurse caring for the patient. She indicated the patient was well. He was walking the floors and asking to go home. He was reported to have an ulceration in his mouth and had a slightly elevated creatinine the day prior which was repeated but the result was pending. Following several unsuccessful follow attempts the patient was reached himself four days later. He reported he had been released from the hospital the day prior after his upper gastrointestinal tract was scoped. He indicated he had burns to his esophagus but his stomach and small intestine were unaffected. He was given medication for this which he could not list. He reported he felt much better and his kidney enzyme elevation had fully resolved. He indicated his doctor had stated he should make a full recovery, but had set a recheck appointment in five weeks to assure he had healed well. The patient was unwilling to provide his doctors name for further follow up when asked. No further information is available.
Majeure